65FR38292A Biological Response Modifiers Advisory Committee; Notice of Meeting
robop...@us.govnews.org
Posting-number: Volume 65, Issue 119, Page 38292A
[Federal Register: June 20, 2000 (Volume 65, Number 119)]
[Notices]
[Page 38292-38293]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20jn00-81]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Biological Response Modifiers Advisory Committee; Notice of
Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration
[[Page 38293]]
(FDA). The meeting will be open to the public.
Name of Committee: Biological Response Modifiers Advisory
Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on July 13, 2000, 8:30 a.m.
to 6 p.m. and July 14, 2000, 8:30 a.m. to 3 p.m.
Location: Hilton Hotel, 620 Perry Pkwy., Gaithersburg, MD.
Contact Person: Gail Dapolito or Rosanna Harvey (HFM-71), Food and
Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-
0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-
443-0572 in the Washington, DC area), code 12389. Please call the
Information Line for up-to-date information on this meeting.
Agenda: On July 13 and 14, 2000, the committee will discuss product
development issues related to human stem cells as cellular replacement
therapies for neurological disorders.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by June 30, 2000.
Oral presentations from the public will be scheduled between
approximately 9 a.m. and 10 a.m. on July 14, 2000. Time allotted for
each presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person before June 30, 2000,
and submit a brief statement of the general nature of the evidence or
arguments they wish to present, the names and addresses of proposed
participants, and an indication of the approximate time requested to
make their presentation.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: June 9, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-15431 Filed 6-19-00; 8:45 am]
BILLING CODE 4160-01-F